New Treatment Approved for Prostate Cancer That Resists Hormone Therapy

WEDNESDAY, Feb. 14, 2018 -- Erleada (apalutamide) has been approved by the U.S. Food and Drug Administration to treat non-spreading prostate cancer that continues to grow despite hormone therapy. Prostate cancer is the second-most-common form of the...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news